Bristow RG - Search Results

1

Temporal Stability and Prognostic Biomarker Potential of the Prostate Cancer Urine miRNA Transcriptome.

Jeon J, Olkhov-Mitsel E, Xie H, Yao CQ, Zhao F, Jahangiri S, Cuizon C, Scarcello S, Jeyapala R, Watson JD, Fraser M, Ray J, Commisso K, Loblaw A, Fleshner NE, Bristow RG, Downes M, Vesprini D, Liu S, Bapat B, Boutros PC. Jeon J, et al. Among authors: bristow rg. J Natl Cancer Inst. 2020 Mar 1;112(3):247-255. doi: 10.1093/jnci/djz112. J Natl Cancer Inst. 2020. PMID: 31161221 Free PMC article.

2

Optimal treatment of intermediate-risk prostate carcinoma with radiotherapy: clinical and translational issues.

Nichol AM, Warde P, Bristow RG. Nichol AM, et al. Among authors: bristow rg. Cancer. 2005 Sep 1;104(5):891-905. doi: 10.1002/cncr.21257. Cancer. 2005. PMID: 16007687 Free article. Review.

3

Homologous recombination and prostate cancer: a model for novel DNA repair targets and therapies.

Bristow RG, Ozcelik H, Jalali F, Chan N, Vesprini D. Bristow RG, et al. Radiother Oncol. 2007 Jun;83(3):220-30. doi: 10.1016/j.radonc.2007.04.016. Epub 2007 May 24. Radiother Oncol. 2007. PMID: 17531338 Review.

4

A phase I trial of pre-operative radiotherapy for prostate cancer: clinical and translational studies.

Supiot S, Shubbar S, Fleshner N, Warde P, Hersey K, Wallace K, Cole H, Sweet J, Tsihlias J, Jewett MA, Klotz L, Bristow RG. Supiot S, et al. Among authors: bristow rg. Radiother Oncol. 2008 Jul;88(1):53-60. doi: 10.1016/j.radonc.2008.03.019. Epub 2008 Apr 16. Radiother Oncol. 2008. PMID: 18423916 Clinical Trial.

5

Practical approaches to proteomic biomarkers within prostate cancer radiotherapy trials.

Christensen E, Evans KR, Ménard C, Pintilie M, Bristow RG. Christensen E, et al. Among authors: bristow rg. Cancer Metastasis Rev. 2008 Sep;27(3):375-85. doi: 10.1007/s10555-008-9139-6. Cancer Metastasis Rev. 2008. PMID: 18427732 Review.

6

A novel poly(ADP-ribose) polymerase inhibitor, ABT-888, radiosensitizes malignant human cell lines under hypoxia.

Liu SK, Coackley C, Krause M, Jalali F, Chan N, Bristow RG. Liu SK, et al. Among authors: bristow rg. Radiother Oncol. 2008 Aug;88(2):258-68. doi: 10.1016/j.radonc.2008.04.005. Epub 2008 May 2. Radiother Oncol. 2008. PMID: 18456354

7

Biomarkers for DNA DSB inhibitors and radiotherapy clinical trials.

Liu SK, Olive PL, Bristow RG. Liu SK, et al. Among authors: bristow rg. Cancer Metastasis Rev. 2008 Sep;27(3):445-58. doi: 10.1007/s10555-008-9137-8. Cancer Metastasis Rev. 2008. PMID: 18516501 Review.

8

Longitudinal cytokine expression during IMRT for prostate cancer and acute treatment toxicity.

Christensen E, Pintilie M, Evans KR, Lenarduzzi M, Ménard C, Catton CN, Diamandis EP, Bristow RG. Christensen E, et al. Among authors: bristow rg. Clin Cancer Res. 2009 Sep 1;15(17):5576-83. doi: 10.1158/1078-0432.CCR-09-0245. Epub 2009 Aug 25. Clin Cancer Res. 2009. PMID: 19706801 Free article.

9

Array CGH as a potential predictor of radiocurability in intermediate risk prostate cancer.

Ishkanian AS, Zafarana G, Thoms J, Bristow RG. Ishkanian AS, et al. Among authors: bristow rg. Acta Oncol. 2010 Oct;49(7):888-94. doi: 10.3109/0284186X.2010.499371. Acta Oncol. 2010. PMID: 20590366 Review.

10

Neoadjuvant radiotherapy for locally advanced and high-risk prostate cancer.

Thoms J, Goda JS, Zlotta AR, Fleshner NE, van der Kwast TH, Supiot S, Warde P, Bristow RG. Thoms J, et al. Among authors: bristow rg. Nat Rev Clin Oncol. 2011 Feb;8(2):107-13. doi: 10.1038/nrclinonc.2010.207. Epub 2010 Dec 21. Nat Rev Clin Oncol. 2011. PMID: 21178999 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

359 results

Search Page

Filters